Registration for this session is additional to the congress registration fee and is €122 on site.
Aims : Access educational materials here to summarise the current treatment strategies for pulmonary arterial hypertension (PAH) in light of the results of recent clinical trials, and to discuss ongoing investigations on different pathways that may shape future PAH treatment.
Target audience :
Critical/Intensive care physician, General practitioner, Nurse, Patient, Physiotherapist, Student, Adult pulmonologist/Clinician
General respiratory patient care, Transplantation